AKT1 and lung carcinoma: 2.4. Low Concentrations of Shikonin Have a Synergistic Effect When Combined with PI3K-Akt-mTOR Inhibitor (BEZ235) to Reduce the Survival of Chemoresistant Lung Cancer Cells